Clinical Characteristics of Subjects
| Characteristic | NL | MCI | AD | DLB | FTD | ||||
|---|---|---|---|---|---|---|---|---|---|
| No. | 110 | 114 | 199 | 27 | 98 | ||||
| Age* (y) | 65 (8), 50–85 | 68 (8), 50–82 | 70 (8), 50–85 | 66 (8), 50–83 | 64 (8), 50–85 | ||||
| Education* (y) | 15 (3), 10–18 | 13 (4), 10–18 | 10 (4), 5–18 | 11 (5), 3–18 | 12 (4), 4–18 | ||||
| Female (%) | 60 | 60 | 67 | 55 | 47 | ||||
| MMSE* | 29.5 (0.8), 28–30 | 27.5 (1.9), 24–30 | 21.5 (4.2), 9–30 | 22.9 (4.1), 15–30 | 22.5 (5.1), 6–30 | ||||
| Clinical subgroup | Amnesic MCI | Nonamnesic MCI | Mild | Moderate to severe | Mild | Moderate to severe | Mild | Moderate to severe | |
| No. | 78 | 36 | 75 | 123 | 14 | 12 | 57 | 41 | |
| Age† (y) | 67 (9) | 69 (9) | 70 (8) | 71 (8) | 64 (9) | 69 (8) | 65 (9) | 65 (9) | |
| Education† (y) | 13 (4) | 14 (3) | 11 (4) | 9 (4) | 10 (4) | 11 (5) | 12 (4) | 11 (3) | |
| Female (%) | 58 | 61 | 65 | 69 | 54 | 58 | 45 | 53 | |
| MMSE† | 27.2 (2.1) | 27.6 (2.0) | 25.7 (1.4) | 19.2 (3.4) | 26.0 (2.6) | 20.6 (2.6) | 25.9 (1.3) | 17.7 (4.6) | |